It’s been a tough road recently for shareholders of drugstore giant CVS Health (NYSE: CVS). The company has shown moderate results in its front-of-the-store business (think shampoo, diapers, soap, chips and beer), with comps (sales at stores open more than a year) falling 1 percent during the most recent quarter. But the pharmacy business keeps humming along nicely, with comps rising 3.4 percent during the same time frame. The reason for the stock’s recent fall has to do with pharmacy accounts leaving CVS and migrating over to rival Walgreens Boots Alliance. Prime Therapeutics - the nation’s fourth-largest pharmacy benefits manager - and Tricare - which provides insurance to active-duty and retired military personnel - decided to use Walgreens to meet their members’ prescription needs. Those changes caused CVS to lower its expectations for the coming year. The stock has already fallen 30 percent from its May highs.
Continue reading »